The detection and management of Adverse drug reactions (ADRs) is gaining paramount importance in healthcare organizations and regulatory agencies. Such importance originates from the high contribution of ADRs towards medical problems and patient outcomes and their direct linkages with drug discovery and management. Especially in resource bounded situations, the acquisition of ADR-related information and the management of ADR-specific consequences continued to be challenged by the inefficiency of spontaneous reporting systems, the difficulty of promoting self-reporting by patients and the orchestration of socially-generated information through the use of social media networks. To investigate the context of ADR management information in Al Ah...
International audienceBackground: The underreporting of adverse drug reactions (ADRs) through tradit...
Adverse Drug Reactions (ADRs) are a significant public health concern, and the reporting and monitor...
© 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group. Objectives: Adverse drug react...
Healthcare organizations are focusing on the identification and management of Adverse drug reactions...
Adverse drug reactions (ADRs) represent a serious worldwide public health problem. Current post-mark...
International audienceAdverse drug reactions (ADRs) are an important cause of morbidity and mortalit...
Adverse drug reactions (ADRs) represent a serious worldwide public health problem. Current post-mark...
Adverse Drug Reactions (ADRs) has become a worldwide problem that draws the attention of people from...
Objective: Automatic monitoring of Adverse Drug Reactions (ADRs), defined as adverse patient outcome...
Widespread coordination and sharing of information regarding adverse drug reactions (ADRs) are impor...
Patient reporting of adverse drug reactions (ADRs) has become an important element of pharmacovigila...
International audienceSocial media is a potential source of information on postmarketing drug safety...
AbstractObjectiveAutomatic monitoring of Adverse Drug Reactions (ADRs), defined as adverse patient o...
Adverse Drug Reaction (ADR) has become a central concern for many healthcare providers [15]. It is w...
Abstract—Discovering unknown adverse drug reactions (ADRs) in postmarketing surveillance as early as...
International audienceBackground: The underreporting of adverse drug reactions (ADRs) through tradit...
Adverse Drug Reactions (ADRs) are a significant public health concern, and the reporting and monitor...
© 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group. Objectives: Adverse drug react...
Healthcare organizations are focusing on the identification and management of Adverse drug reactions...
Adverse drug reactions (ADRs) represent a serious worldwide public health problem. Current post-mark...
International audienceAdverse drug reactions (ADRs) are an important cause of morbidity and mortalit...
Adverse drug reactions (ADRs) represent a serious worldwide public health problem. Current post-mark...
Adverse Drug Reactions (ADRs) has become a worldwide problem that draws the attention of people from...
Objective: Automatic monitoring of Adverse Drug Reactions (ADRs), defined as adverse patient outcome...
Widespread coordination and sharing of information regarding adverse drug reactions (ADRs) are impor...
Patient reporting of adverse drug reactions (ADRs) has become an important element of pharmacovigila...
International audienceSocial media is a potential source of information on postmarketing drug safety...
AbstractObjectiveAutomatic monitoring of Adverse Drug Reactions (ADRs), defined as adverse patient o...
Adverse Drug Reaction (ADR) has become a central concern for many healthcare providers [15]. It is w...
Abstract—Discovering unknown adverse drug reactions (ADRs) in postmarketing surveillance as early as...
International audienceBackground: The underreporting of adverse drug reactions (ADRs) through tradit...
Adverse Drug Reactions (ADRs) are a significant public health concern, and the reporting and monitor...
© 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group. Objectives: Adverse drug react...